MEG3 long non-coding RNA prevents cell growth and metastasis of osteosarcoma

Abstract

Insights

Long non-coding RNA MEG3 (lncRNA MEG3) is downregulated in osteosarcoma (OS). Overexpressing MEG3 inhibits OS cell proliferation and metastasis by suppressing Notch and TGF-β signaling pathways.

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • Osteosarcoma (OS) is a primary bone malignancy with significant metastatic potential.
  • Long non-coding RNAs (lncRNAs) play crucial roles in various cellular processes, including cancer development.
  • The specific role of lncRNA MEG3 in OS pathogenesis requires further elucidation.

Purpose of the Study:

  • To investigate the role of lncRNA MEG3 in osteosarcoma.
  • To explore the underlying molecular mechanisms by which MEG3 influences OS cell behavior.
  • To assess the therapeutic potential of MEG3 in OS treatment.

Main Methods:

  • Quantitative real-time PCR (qRT-PCR) to determine MEG3 expression levels in OS cell lines and normal osteoblasts.
  • Lentiviral vector (LV-MEG3) mediated overexpression of MEG3 in OS cells.
  • MTT and colony-formation assays to evaluate cell proliferation.
  • Cell migration assays to assess metastatic potential.
  • Western blot analysis to determine the expression of key signaling molecules (Notch1, Hes1, TGF-β, N-cadherin, E-cadherin).

Main Results:

  • MEG3 expression was significantly downregulated in OS cell lines (MG63, U2OS) compared to normal osteoblasts (hFOB1.19).
  • Overexpression of MEG3 in MG63 cells via LV-MEG3 significantly inhibited cell proliferation and migration.
  • MEG3 overexpression markedly suppressed the expression of Notch1, Hes1, TGF-β, and N-cadherin, while increasing E-cadherin expression.

Conclusions:

  • lncRNA MEG3 acts as a tumor suppressor in osteosarcoma.
  • MEG3 inhibits OS cell growth and metastasis by repressing the Notch and TGF-β signaling pathways.
  • MEG3 represents a potential therapeutic target for osteosarcoma treatment.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.1K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.0K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
7.8K